4/A//SEC Filing
SOPHIRIS BIO INC. 4/A
Accession 0001209191-13-049645
CIK 0001563855operating
Filed
Oct 28, 8:00 PM ET
Accepted
Oct 29, 1:48 PM ET
Size
5.8 KB
Accession
0001209191-13-049645
Insider Transaction Report
Form 4/AAmended
HULME ALLISON
Chief Operating Officer
Transactions
- Award
Common Stock (Right to Buy)
2013-10-25+178,641→ 178,641 totalExercise: $4.41From: 2014-10-25Exp: 2018-10-24→ Common Stock (178,641 underlying)
Footnotes (2)
- [F1]Due to an administrative error, the number of derivative securities acquired was incorrectly shown as 430,375 instead of 178,641.
- [F2]33% of the shares subject to the option shall vest one year after the date of grant. The remainder shall vest monthly thereafter over the next two years until fully vested on October 25, 2016.
Documents
Issuer
SOPHIRIS BIO INC.
CIK 0001563855
Entity typeoperating
IncorporatedBritish Columbia, Canada
Related Parties
1- filerCIK 0001563855
Filing Metadata
- Form type
- 4/A
- Filed
- Oct 28, 8:00 PM ET
- Accepted
- Oct 29, 1:48 PM ET
- Size
- 5.8 KB